SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Morgan Stanley – ‘10-K’ for 12/31/18 – ‘R21’

On:  Tuesday, 2/26/19, at 4:12pm ET   ·   For:  12/31/18   ·   Accession #:  1193125-19-51943   ·   File #:  1-11758

Previous ‘10-K’:  ‘10-K’ on 2/27/18 for 12/31/17   ·   Next:  ‘10-K’ on 2/27/20 for 12/31/19   ·   Latest:  ‘10-K’ on 2/22/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/19  Morgan Stanley                    10-K       12/31/18  188:49M                                    Donnelley … Solutions/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.85M 
 4: EX-10.24    Material Contract                                   HTML     56K 
 5: EX-10.30    Material Contract                                   HTML    169K 
 2: EX-10.4     Material Contract                                   HTML     69K 
 3: EX-10.6     Material Contract                                   HTML    118K 
 6: EX-21       Subsidiaries List                                   HTML     60K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML     64K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     58K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     58K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     53K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     53K 
18: R1          Document and Entity Information                     HTML     82K 
19: R2          Consolidated Income Statements                      HTML    163K 
20: R3          Consolidated Comprehensive Income Statements        HTML     83K 
21: R4          Consolidated Balance Sheets                         HTML    152K 
22: R5          Consolidated Balance Sheets (Parenthetical)         HTML     82K 
23: R6          Consolidated Statements of Changes in Total Equity  HTML    109K 
24: R7          Consolidated Statements of Changes in Total Equity  HTML     58K 
                (Parenthetical)                                                  
25: R8          Consolidated Cash Flow Statements                   HTML    164K 
26: R9          Introduction and Basis of Presentation              HTML     74K 
27: R10         Significant Accounting Policies                     HTML    198K 
28: R11         Fair Value Disclosures                              HTML   1.28M 
29: R12         Derivative Instruments and Hedging Activities       HTML    530K 
30: R13         Investment Securities                               HTML    502K 
31: R14         Collateralized Transactions                         HTML    283K 
32: R15         Loans, Lending Commitments and Allowance for        HTML    421K 
                Credit Losses                                                    
33: R16         Equity Method Investments                           HTML     70K 
34: R17         Goodwill and Intangible Assets                      HTML    152K 
35: R18         Deposits                                            HTML     77K 
36: R19         Borrowings and Other Secured Financings             HTML    220K 
37: R20         Commitments, Guarantees and Contingencies           HTML    262K 
38: R21         Variable Interest Entities and Securitization       HTML    382K 
                Activities                                                       
39: R22         Regulatory Requirements                             HTML    221K 
40: R23         Total Equity                                        HTML    379K 
41: R24         Earnings per Common Share                           HTML    119K 
42: R25         Interest Income and Interest Expense                HTML     90K 
43: R26         Deferred Compensation Plans                         HTML    176K 
44: R27         Employee Benefit Plans                              HTML    391K 
45: R28         Income Taxes                                        HTML    215K 
46: R29         Segment, Geographic and Revenue Information         HTML    426K 
47: R30         Parent Company                                      HTML    291K 
48: R31         Quarterly Results                                   HTML    251K 
49: R32         Subsequent Events                                   HTML     56K 
50: R33         Significant Accounting Policies (Policy)            HTML    247K 
51: R34         Significant Accounting Policies (Tables)            HTML     60K 
52: R35         Fair Value Disclosures (Tables)                     HTML   1.21M 
53: R36         Derivative Instruments and Hedging Activities       HTML    529K 
                (Tables)                                                         
54: R37         Investment Securities (Tables)                      HTML    505K 
55: R38         Collateralized Transactions (Tables)                HTML    280K 
56: R39         Loans, Lending Commitments and Allowance for        HTML    416K 
                Credit Losses (Tables)                                           
57: R40         Equity Method Investments (Tables)                  HTML     69K 
58: R41         Goodwill and Intangible Assets (Tables)             HTML    156K 
59: R42         Deposits (Tables)                                   HTML     77K 
60: R43         Borrowings and Other Secured Financings (Tables)    HTML    222K 
61: R44         Commitments, Guarantees and Contingencies (Tables)  HTML    215K 
62: R45         Variable Interest Entities and Securitization       HTML    357K 
                Activities (Tables)                                              
63: R46         Regulatory Requirements (Tables)                    HTML    208K 
64: R47         Total Equity (Tables)                               HTML    381K 
65: R48         Earnings per Common Share (Tables)                  HTML    119K 
66: R49         Interest Income and Interest Expense (Tables)       HTML     88K 
67: R50         Deferred Compensation Plans (Tables)                HTML    189K 
68: R51         Employee Benefit Plans (Tables)                     HTML    396K 
69: R52         Income Taxes (Tables)                               HTML    216K 
70: R53         Segment, Geographic and Revenue Information         HTML    433K 
                (Tables)                                                         
71: R54         Parent Company (Tables)                             HTML    289K 
72: R55         Quarterly Results (Tables)                          HTML    253K 
73: R56         Significant Accounting Policies (Details)           HTML     88K 
74: R57         Fair Value Disclosures (Assets and Liabilities      HTML    219K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
75: R58         Fair Value Disclosures (Rollforward of Level 3      HTML    185K 
                Assets and Liabilities Measured at Fair Value on a               
                Recurring Basis) (Details)                                       
76: R59         Fair Value Disclosures (Valuation Techniques and    HTML    366K 
                Sensitivity of Unobservable Inputs Used in Level 3               
                Fair Value Measurements) (Details)                               
77: R60         Fair Value Disclosures (Fund Interests Measured     HTML     76K 
                Based on Net Asset Value) (Details)                              
78: R61         Fair Value Disclosures (Borrowings Measured at      HTML     69K 
                Fair Value on a Recurring Basis) (Details)                       
79: R62         Fair Value Disclosures (Earnings Impact of          HTML     61K 
                Borrowings under the Fair Value Option) (Details)                
80: R63         Fair Value Disclosures (Gains (Losses) Due to       HTML     73K 
                Changes in Instrument-Specific Credit Risk)                      
                (Details)                                                        
81: R64         Fair Value Disclosures (Excess of Contractual       HTML     59K 
                Principal Amount Over Fair Value) (Details)                      
82: R65         Fair Value Disclosures (Fair Value Loans on         HTML     57K 
                Nonaccrual Status) (Details)                                     
83: R66         Fair Value Disclosures (Assets and Liabilities      HTML     96K 
                Measured at Fair Value on a Nonrecurring Basis)                  
                (Details)                                                        
84: R67         Fair Value Disclosures (Financial Instruments Not   HTML    142K 
                Measured at Fair Value) (Details)                                
85: R68         Derivative Instruments and Hedging Activities       HTML    200K 
                (Derivative Fair Values) (Details)                               
86: R69         Derivative Instruments and Hedging Activities       HTML    123K 
                (Derivative Notionals) (Details)                                 
87: R70         Derivative Instruments and Hedging Activities       HTML     81K 
                (Gains (Losses) on Accounting Hedges and Fair                    
                Value Hedges) (Details)                                          
88: R71         Derivative Instruments and Hedging Activities       HTML     67K 
                (Credit Risk-Related Contingencies) (Details)                    
89: R72         Derivative Instruments and Hedging Activities       HTML    115K 
                (Maximum Potential Payout/Notional of Credit                     
                Protection Sold) (Details)                                       
90: R73         Derivative Instruments and Hedging Activities       HTML     72K 
                (Fair Value (Asset)/Liability of Credit Protection               
                Sold) (Details)                                                  
91: R74         Derivative Instruments and Hedging Activities       HTML     68K 
                (Protection Purchased with CDS) (Details)                        
92: R75         Investment Securities (AFS and HTM Securities)      HTML    150K 
                (Details)                                                        
93: R76         Investment Securities (Investment Securities in an  HTML    158K 
                Unrealized Loss Position) (Details)                              
94: R77         Investment Securities (Investment Securities by     HTML    223K 
                Contractual Maturity) (Details)                                  
95: R78         Investment Securities (Gross Realized Gains and     HTML     60K 
                Losses on Sales of AFS Securities) (Details)                     
96: R79         Collateralized Transactions (Offsetting of Certain  HTML    128K 
                Collateralized Transactions) (Details)                           
97: R80         Collateralized Transactions (Gross Secured          HTML     98K 
                Financing Balances) (Details)                                    
98: R81         Collateralized Transactions (Assets Loaned or       HTML     60K 
                Pledged) (Details)                                               
99: R82         Collateralized Transactions (Collateral Received)   HTML     57K 
                (Details)                                                        
100: R83         Collateralized Transactions (Restricted Cash and    HTML     61K  
                Segregated Securities) (Details)                                 
101: R84         Collateralized Transactions (Concentration Risk)    HTML     61K  
                (Details)                                                        
102: R85         Collateralized Transactions (Customer Margin        HTML     54K  
                Lending) (Details)                                               
103: R86         Loans, Lending Commitments and Allowance for        HTML    141K  
                Credit Losses (Loans by Type) (Details)                          
104: R87         Loans, Lending Commitments and Allowance for        HTML     89K  
                Credit Losses (Impaired Loans and Lending                        
                Commitments) (Details)                                           
105: R88         Loans, Lending Commitments and Allowance for        HTML     58K  
                Credit Losses (Tdr) (Details)                                    
106: R89         Loans, Lending Commitments and Allowance for        HTML    117K  
                Credit Losses (Allowance for Loan Losses and                     
                Lending Commitments Rollforward) (Details)                       
107: R90         Loans, Lending Commitments and Allowance for        HTML     64K  
                Credit Losses (Employee Loans) (Details)                         
108: R91         Equity Method Investments (Equity Method            HTML     66K  
                Investment Balances) (Details)                                   
109: R92         Equity Method Investments (Investees) (Details)     HTML     64K  
110: R93         Goodwill and Intangible Assets (Goodwill            HTML     77K  
                Rollforward) (Details)                                           
111: R94         Goodwill and Intangible Assets (Intangible Assets   HTML     69K  
                by Business Segment) (Details)                                   
112: R95         Goodwill and Intangible Assets (Gross Amortizable   HTML     84K  
                Intangible Assets by Type) (Details)                             
113: R96         Goodwill and Intangible Assets (Net Amortizable     HTML     75K  
                Intangible Assets Rollforward) (Details)                         
114: R97         Deposits (Details)                                  HTML     78K  
115: R98         Borrowings and Other Secured Financings             HTML    109K  
                (Maturities and Terms of Borrowings) (Details)                   
116: R99         Borrowings and Other Secured Financings (Long-Term  HTML     76K  
                Borrowings) (Details)                                            
117: R100        Borrowings and Other Secured Financings (Rates for  HTML     56K  
                Long-Term Borrowings) (Details)                                  
118: R101        Borrowings and Other Secured Financings (Other      HTML     61K  
                Secured Financings) (Details)                                    
119: R102        Borrowings and Other Secured Financings             HTML     96K  
                (Maturities and Terms of Secured Financings)                     
                (Details)                                                        
120: R103        Borrowings and Other Secured Financings (Failed     HTML     69K  
                Sales by Maturity) (Details)                                     
121: R104        Commitments, Guarantees and Contingencies           HTML     89K  
                (Commitments) (Details)                                          
122: R105        Commitments, Guarantees and Contingencies           HTML     78K  
                (Operating Premises Leases) (Details)                            
123: R106        Commitments, Guarantees and Contingencies           HTML    126K  
                (Obligations under Guarantee Arrangements)                       
                (Details)                                                        
124: R107        Commitments, Guarantees and Contingencies           HTML    118K  
                (Contingencies) (Details)                                        
125: R108        Variable Interest Entities and Securitization       HTML     65K  
                Activities (Assets and Liabilities by Type of                    
                Activity) (Details)                                              
126: R109        Variable Interest Entities and Securitization       HTML     90K  
                Activities (Assets and Liabilities by Balance                    
                Sheet Caption) (Details)                                         
127: R110        Variable Interest Entities and Securitization       HTML    131K  
                Activities (Non-Consolidated VIEs) (Details)                     
128: R111        Variable Interest Entities and Securitization       HTML    100K  
                Activities (Transfers of Assets with Continuing                  
                Involvement 1) (Details)                                         
129: R112        Variable Interest Entities and Securitization       HTML     85K  
                Activities (Transfers of Assets with Continuing                  
                Involvement 2) (Details)                                         
130: R113        Variable Interest Entities and Securitization       HTML     64K  
                Activities (Proceeds from New Securitization                     
                Transactions and Sales of Loans) (Details)                       
131: R114        Variable Interest Entities and Securitization       HTML     68K  
                Activities (Assets Sold with Retained Exposure)                  
                (Details)                                                        
132: R115        Regulatory Requirements (Narrative) (Details)       HTML     60K  
133: R116        Regulatory Requirements (Capital Measures)          HTML     97K  
                (Details)                                                        
134: R117        Regulatory Requirements (U.S. Bank Subsidiaries'    HTML    106K  
                Regulatory Capital and Capital Ratios) (Details)                 
135: R118        Regulatory Requirements (U.S. Broker-Dealer         HTML     62K  
                Regulatory Capital Requirements) (Details)                       
136: R119        Regulatory Requirements (Restricted Net Assets)     HTML     55K  
                (Details)                                                        
137: R120        Total Equity (Rollforward of Common Stock           HTML     62K  
                Outstanding) (Details)                                           
138: R121        Total Equity (Dividends and Share Repurchases)      HTML     79K  
                (Details)                                                        
139: R122        Total Equity (Preferred Stock Outstanding)          HTML    103K  
                (Details)                                                        
140: R123        Total Equity (Preferred Stock Issuance              HTML     92K  
                Description) (Details)                                           
141: R124        Total Equity (Preferred Stock Dividends) (Details)  HTML     83K  
142: R125        Total Equity (Aoci) (Details)                       HTML     73K  
143: R126        Total Equity (Components of Period Changes in OCI   HTML    193K  
                ) (Details)                                                      
144: R127        Total Equity (Cumulative Adjustments to Retained    HTML     68K  
                Earnings) (Details)                                              
145: R128        Total Equity (Cumulative Foreign Currency           HTML     63K  
                Translation Adjustments) (Details)                               
146: R129        Earnings per Common Share (Calculation of Basic     HTML    125K  
                and Diluted EPS) (Details)                                       
147: R130        Interest Income and Interest Expense (Details)      HTML     87K  
148: R131        Deferred Compensation Plans (Stock-based            HTML     82K  
                Compensation Plans) (Details)                                    
149: R132        Deferred Compensation Plans (Vested and Unvested    HTML     82K  
                RSU Activity) (Details)                                          
150: R133        Deferred Compensation Plans (Unvested RSU           HTML     83K  
                Activity) (Details)                                              
151: R134        Deferred Compensation Plans (Performance-Based      HTML     73K  
                Stock Units) (Details)                                           
152: R135        Deferred Compensation Plans (Monte Carlo            HTML     67K  
                Simulation Assumptions) (Details)                                
153: R136        Deferred Compensation Plans (Deferred Cash-based    HTML     73K  
                Compensation Plans) (Details)                                    
154: R137        Deferred Compensation Plans (Annual Compensation    HTML     80K  
                Cost for 2018 Performance Year Awards) (Details)                 
155: R138        Employee Benefit Plans (Net Periodic Benefit        HTML    109K  
                Expense (Income)) (Details)                                      
156: R139        Employee Benefit Plans (Rollforward of the Benefit  HTML    119K  
                Obligation and Fair Value of Plan Assets)                        
                (Details)                                                        
157: R140        Employee Benefit Plans (Accumulated Benefit         HTML     65K  
                Obligation, and Pension Plans with Benefit                       
                Obligations in Excess of the Fair Value of Plan                  
                Assets) (Details)                                                
158: R141        Employee Benefit Plans (Assumptions) (Details)      HTML     76K  
159: R142        Employee Benefit Plans (Fair Value of Plan Assets)  HTML    135K  
                (Details)                                                        
160: R143        Employee Benefit Plans (Rollforward of Level 3      HTML     64K  
                Plan Assets) (Details)                                           
161: R144        Employee Benefit Plans (Expected Future Benefit     HTML     71K  
                Payments) (Details)                                              
162: R145        Employee Benefit Plans (401(k) and Defined          HTML     67K  
                Contribution Pension Plans) (Details)                            
163: R146        Income Taxes (Provision for (Benefit from) Income   HTML    126K  
                Taxes) (Details)                                                 
164: R147        Income Taxes (Effective Income Tax Rate) (Details)  HTML     92K  
165: R148        Income Taxes (Deferred Tax Assets and Liabilities)  HTML     84K  
                (Details)                                                        
166: R149        Income Taxes (Unrecognized Tax Benefits) (Details)  HTML     76K  
167: R150        Income Taxes (Earliest Tax Year Subject to          HTML     63K  
                Examination in Major Tax Jurisdictions) (Details)                
168: R151        Segment, Geographic and Revenue Information         HTML    197K  
                (Selected Financial Information by Business                      
                Segment) (Details)                                               
169: R152        Segment, Geographic and Revenue Information (Net    HTML     80K  
                Discrete Tax Provision (Benefit) by Segment)                     
                (Details)                                                        
170: R153        Segment, Geographic and Revenue Information         HTML     62K  
                (Assets by Business Segment) (Details)                           
171: R154        Segment, Geographic and Revenue Information         HTML     58K  
                (Additional Information - Investment Management)                 
                (Details)                                                        
172: R155        Segment, Geographic and Revenue Information (Net    HTML     67K  
                Revenues by Region) (Details)                                    
173: R156        Segment, Geographic and Revenue Information         HTML     64K  
                (Income by Region) (Details)                                     
174: R157        Segment, Geographic and Revenue Information (Total  HTML     61K  
                Assets by Region) (Details)                                      
175: R158        Segment, Geographic and Revenue Information         HTML     68K  
                (Trading Revenues by Product Type) (Details)                     
176: R159        Segment, Geographic and Revenue Information         HTML     88K  
                (Change in Revenue) (Details)                                    
177: R160        Segment, Geographic and Revenue Information         HTML     56K  
                (Receivables from Contracts with Customers)                      
                (Details)                                                        
178: R161        Parent Company (Condensed Income Statements and     HTML    132K  
                Comprehensive Income Statements) (Details)                       
179: R162        Parent Company (Condensed Balance Sheets)           HTML    171K  
                (Details)                                                        
180: R163        Parent Company (Condensed Cash Flow Statements)     HTML    163K  
                (Details)                                                        
181: R164        Parent Company (Long-Term Borrowings) (Details)     HTML     65K  
182: R165        Parent Company (Guarantees) (Details)               HTML     60K  
183: R166        Quarterly Results (Unaudited) (Details)             HTML    130K  
184: R167        Quarterly Results (Unaudited) (Subnote) (Details)   HTML     63K  
185: R168        Quarterly Results (Change in Revenue) (Details)     HTML     63K  
187: XML         IDEA XML File -- Filing Summary                      XML    384K  
186: EXCEL       IDEA Workbook of Financial Reports                  XLSX    321K  
12: EX-101.INS  XBRL Instance -- ms-20181231                         XML  20.23M 
14: EX-101.CAL  XBRL Calculations -- ms-20181231_cal                 XML    652K 
15: EX-101.DEF  XBRL Definitions -- ms-20181231_def                  XML   3.52M 
16: EX-101.LAB  XBRL Labels -- ms-20181231_lab                       XML   6.42M 
17: EX-101.PRE  XBRL Presentations -- ms-20181231_pre                XML   4.73M 
13: EX-101.SCH  XBRL Schema -- ms-20181231                           XSD    678K 
188: ZIP         XBRL Zipped Folder -- 0001193125-19-051943-xbrl      Zip   1.19M  


‘R21’   —   Variable Interest Entities and Securitization Activities


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.10.0.1
Variable Interest Entities and Securitization Activities
12 Months Ended
Variable Interest Entities and Securitization Activities [Abstract]  
Variable Interest Entity Disclosures

13. Variable Interest Entities and Securitization Activities

Overview

The Firm is involved with various SPEs in the normal course of business. In most cases, these entities are deemed to be VIEs.

The Firm’s variable interests in VIEs include debt and equity interests, commitments, guarantees, derivative instruments and certain fees. The Firm’s involvement with VIEs arises primarily from:

 

Interests purchased in connection with market-making activities, securities held in its Investment securities portfolio and retained interests held as a result of securitization activities, including re-securitization transactions.

 

Guarantees issued and residual interests retained in connection with municipal bond securitizations.

 

Loans made to and investments in VIEs that hold debt, equity, real estate or other assets.

 

Derivatives entered into with VIEs.

 

Structuring of CLNs or other asset-repackaged notes designed to meet the investment objectives of clients.

 

Other structured transactions designed to provide tax-efficient yields to the Firm or its clients.

The Firm determines whether it is the primary beneficiary of a VIE upon its initial involvement with the VIE and reassesses whether it is the primary beneficiary on an ongoing basis as long as it has any continuing involvement with the VIE. This determination is based upon an analysis of the design of the VIE, including the VIE’s structure and activities, the power to make significant economic decisions held by the Firm and by other parties, and the variable interests owned by the Firm and other parties.

 

The power to make the most significant economic decisions may take a number of different forms in different types of VIEs. The Firm considers servicing or collateral management decisions as representing the power to make the most significant economic decisions in transactions such as securitizations or CDOs. As a result, the Firm does not consolidate securitizations or CDOs for which it does not act as the servicer or collateral manager unless it holds certain other rights to replace the servicer or collateral manager or to require the liquidation of the entity. If the Firm serves as servicer or collateral manager, or has certain other rights described in the previous sentence, the Firm analyzes the interests in the VIE that it holds and consolidates only those VIEs for which it holds a potentially significant interest in the VIE.

  

For many transactions, such as re-securitization transactions, CLNs and other asset-repackaged notes, there are no significant economic decisions made on an ongoing basis. In these cases, the Firm focuses its analysis on decisions made prior to the initial closing of the transaction and at the termination of the transaction. The Firm concluded in most of these transactions that decisions made prior to the initial closing were shared between the Firm and the initial investors based upon the nature of the assets, including whether the assets were issued in a transaction sponsored by the Firm and the extent of the information available to the Firm and to investors, the number, nature and involvement of investors, other rights held by the Firm and investors, the standardization of the legal documentation and the level of continuing involvement by the Firm, including the amount and type of interests owned by the Firm and by other investors. The Firm focused its control decision on any right held by the Firm or investors related to the termination of the VIE. Most re-securitization transactions, CLNs and other asset-repackaged notes have no such termination rights.

Consolidated VIEs

Assets and Liabilities by Type of Activity
At December 31, 2018At December 31, 2017
$ in millionsVIE AssetsVIE LiabilitiesVIE AssetsVIE Liabilities
OSF$267$$378$3
MABS15938249210
Other2809481,174250
Total$1,135$86$1,801$463

OSF—Other structured financings

1. Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets. The value of assets is determined based on the fair value of the liabilities and the interests owned by the Firm in such VIEs as the fair values for the liabilities and interests owned are more observable.

2. Other primarily includes investment funds, certain operating entities and structured transactions. During 2018, Other included a fund managed by Mesa West Capital, LLC (which was acquired by the Firm in the first quarter of 2018), until the fund was deconsolidated in the fourth quarter of 2018 due to the termination of a credit facility provided by the Firm to this fund.

Assets and Liabilities by Balance Sheet Caption
AtAt
December 31,December 31,
$ in millions20182017
Assets
Cash and cash equivalents:
Cash and due from banks$77$69
Restricted cash171222
Trading assets at fair value314833
Customer and other receivables2519
Goodwill1818
Intangible assets128155
Other assets402485
Total$1,135$1,801
Liabilities
Other secured financings$64$438
Other liabilities and accrued expenses2225
Total$86$463
Noncontrolling interests $106$189

Consolidated VIE assets and liabilities are presented in the previous tables after intercompany eliminations. Most assets owned by consolidated VIEs cannot be removed unilaterally by the Firm and are not generally available to the Firm. Most related liabilities issued by consolidated VIEs are non-recourse to the Firm. In certain other consolidated VIEs, the Firm either has the unilateral right to remove assets or provides additional recourse through derivatives such as total return swaps, guarantees or other forms of involvement.

In general, the Firm’s exposure to loss in consolidated VIEs is limited to losses that would be absorbed on the VIE net assets recognized in its financial statements, net of amounts absorbed by third-party variable interest holders.

Non-consolidated VIEs

At December 31, 2018
$ in millionsMABSCDOMTOBOSFOther
VIE assets (UPB)$71,287$10,848$7,014$3,314$19,682
Maximum exposure to loss1
Debt and equity
interests$8,234$1,169$$1,622$4,645
Derivative and
other contracts 4,4491,768
Commitments,
guarantees
and other3973235327
Total$8,631$1,172$4,449$1,857$6,740
Carrying value of exposure to loss—Assets
Debt and equity
interests$8,234$1,169$$1,205$4,645
Derivative and
other contracts 687
Total$8,234$1,169$6$1,205$4,732
Additional VIE assets owned2$11,969
Carrying value of exposure to loss—Liabilities
Derivative and
other contracts $$$$$185
Total$$$$$185

At December 31, 2017
$ in millionsMABSCDOMTOBOSFOther
VIE assets (UPB)$89,288$9,807$5,306$3,322$31,934
Maximum exposure to loss1
Debt and equity
interests$10,657$1,384$80$1,628$4,730
Derivative and
other contracts 3,3331,686
Commitments,
guarantees
and other 1,214668164433
Total$11,871$2,052$3,413$1,792$6,849
Carrying value of exposure to loss—Assets
Debt and equity
interests$10,657$1,384$43$1,202$4,730
Derivative and
other contracts 5184
Total$10,657$1,384$48$1,202$4,914
Additional VIE assets owned2$11,318

MTOB—Municipal tender option bonds

1. Where notional amounts are utilized in quantifying the maximum exposure related to derivatives, such amounts do not reflect changes in fair value recorded by the Firm.

2. Additional VIE assets owned represents the carrying value of total exposure to non-consolidated VIEs for which the maximum exposure to loss is less than specific thresholds, primarily interests issued by securitization SPEs. The Firms primary risk exposure is to the most subordinate class of beneficial interest and maximum exposure to loss generally equals the fair value of the assets owned. These assets are primarily included in Trading assets and Investment securities and are measured at fair value (see Note 3). The Firm does not provide additional support in these transactions through contractual facilities, guarantees or similar derivatives.

The majority of the VIEs included in the previous tables are sponsored by unrelated parties; the Firm’s involvement generally is the result of its secondary market-making activities, securities held in its Investment securities portfolio (see Note 5) and certain investments in funds.

The Firm’s maximum exposure to loss is dependent on the nature of the Firm’s variable interest in the VIE and is limited to:

notional amounts of certain liquidity facilities;

other credit support;

total return swaps;

written put options; and

fair value of certain other derivatives and investments the Firm has made in the VIE.

The Firm’s maximum exposure to loss in the previous tables does not include the offsetting benefit of hedges or any reductions associated with the amount of collateral held as part of a transaction with the VIE or any party to the VIE directly against a specific exposure to loss.

Liabilities issued by VIEs generally are non-recourse to the Firm.

Mortgage- and Asset-Backed Securitization Assets
At December 31, 2018At December 31, 2017
UPBDebt and Equity InterestsUPBDebt and Equity Interests
$ in millions
Residential mortgages$6,954$745$15,636$1,272
Commercial mortgages42,9741,23746,4642,331
U.S. agency collateralized
mortgage obligations14,9693,44316,2233,439
Other consumer or
commercial loans6,3902,80910,9653,615
Total$71,287$8,234$89,288$10,657

Securitization Activities

In a securitization transaction, the Firm transfers assets (generally commercial or residential mortgage loans or U.S. agency securities) to an SPE, sells to investors most of the beneficial interests, such as notes or certificates, issued by the SPE, and, in many cases, retains other beneficial interests. The purchase of the transferred assets by the SPE is financed through the sale of these interests.

In many securitization transactions involving commercial mortgage loans, the Firm transfers a portion of the assets to the SPE with unrelated parties transferring the remaining assets.

 

In some of these transactions, primarily involving residential mortgage loans in the U.S., the Firm serves as servicer for some or all of the transferred loans. In many securitizations, particularly involving residential mortgage loans, the Firm also enters into derivative transactions, primarily interest rate swaps or interest rate caps, with the SPE.

 

Although not obligated, the Firm generally makes a market in the securities issued by SPEs in securitization transactions. As a market maker, the Firm offers to buy these securities from, and sell these securities to, investors. Securities purchased through these market-making activities are not considered to be retained interests; these beneficial interests generally are included in Trading assets—Corporate and other debt and are measured at fair value.

 

The Firm enters into derivatives, generally interest rate swaps and interest rate caps, with a senior payment priority in many securitization transactions. The risks associated with these and similar derivatives with SPEs are essentially the same as similar derivatives with non-SPE counterparties and are managed as part of the Firm’s overall exposure. See Note 4 for further information on derivative instruments and hedging activities.

Available-for-Sale Securities

The Firm holds AFS issued by VIEs not sponsored by the Firm within the Investment securities portfolio. These securities are composed of those related to transactions sponsored by the federal mortgage agencies and the most senior securities issued by VIEs backed by student loans, automobile loans, commercial mortgage loans or CLOs. Transactions sponsored by the federal mortgage agencies include an explicit or implicit guarantee provided by the U.S. government. See Note 5 for further information on the Investment Securities Portfolio.

 

Municipal Tender Option Bond Trusts

In a municipal tender option bond trust transaction, the client transfers a municipal bond to a trust. The trust issues short-term securities that the Firm, as the remarketing agent, sells to investors. The client generally retains a residual interest. The short-term securities are supported by a liquidity facility pursuant to which the investors may put their short-term interests. In some programs, the Firm provides this liquidity facility; in most programs, a third-party provider will provide such liquidity facility.

The Firm may, in lieu of purchasing short term securities for remarketing, decide to extend a temporary loan to the trust. The client can generally terminate the transaction at any time. The liquidity provider can generally terminate the transaction upon the occurrence of certain events. When the transaction is terminated, the municipal bond is generally sold or returned to the client. Any losses suffered by the liquidity provider upon the sale of the bond are the responsibility of the client. This obligation is generally collateralized. Liquidity facilities provided to municipal tender option bond trusts are classified as derivatives. The Firm consolidates any municipal tender option bond trusts in which it holds the residual interest.

 

Credit Protection Purchased through Credit-Linked Notes

CLN transactions are designed to provide investors with exposure to certain credit risk on referenced asset. In these transactions, the Firm transfers assets (generally high-quality securities or money market investments) to an SPE, enters into a derivative transaction in which the SPE sells protection on an unrelated referenced asset or group of assets, through a credit derivative, and sells the securities issued by the SPE to investors. In some transactions, the Firm may also enter into interest rate or currency swaps with the SPE.

Upon the occurrence of a credit event related to the referenced asset, the SPE will deliver securities collateral as payment to the Firm, which exposes the Firm to changes in the collateral’s value. Depending on the structure, the assets and liabilities of the SPE may be recognized in the Firm’s balance sheets or accounted for as a sale of assets and the SPE is not consolidated.

 

Derivative payments by the SPE are collateralized. The risks associated with these and similar derivatives with SPEs are essentially the same as those with non-SPE counterparties, and are managed as part of the Firm’s overall exposure.

 

Other Structured Financings

The Firm invests in interests issued by entities that develop and own low-income communities (including low-income housing projects) and entities that construct and own facilities that will generate energy from renewable resources. The interests entitle the Firm to a share of tax credits and tax losses generated by these projects. In addition, the Firm has issued guarantees to investors in certain low-income housing funds. The guarantees are designed to return an investor’s contribution to a fund and the investor’s share of tax losses and tax credits expected to be generated by the fund. The Firm is also involved with entities designed to provide tax-efficient yields to the Firm or its clients.

Collateralized Loan and Debt Obligations 

CLOs and CDOs are SPEs that purchase a pool of assets consisting of corporate loans, corporate bonds, ABS or synthetic exposures on similar assets through derivatives, and issues multiple tranches of debt and equity securities to investors. The Firm underwrites the securities issued in CLO transactions on behalf of unaffiliated sponsors and provides advisory services to these unaffiliated sponsors. The Firm sells corporate loans to many of these SPEs, in some cases representing a significant portion of the total assets purchased. Although not obligated, the Firm generally makes a market in the securities issued by SPEs in these transactions and may retain unsold securities. These beneficial interests are included in Trading assets and are measured at fair value.

 

Equity-Linked Notes

ELN transactions are designed to provide investors with exposure to certain risks related to the specific equity security, equity index or other index. In an ELN transaction, the Firm typically transfers to an SPE either a note issued by the Firm, the payments on which are linked to the performance of a specific equity security, equity index, or other index, or debt securities issued by other companies and a derivative contract, the terms of which will relate to the performance of a specific equity security, equity index or other index. These ELN transactions with SPEs were not consolidated at December 31, 2018 and December 31, 2017.

Transfers of Assets with Continuing Involvement 
At December 31, 2018
RMLCMLU.S. Agency CMOCLN and Other1
$ in millions
SPE assets (UPB)2$14,376$68,593$16,594$14,608
Retained interests
Investment grade$17$483$1,573$3
Non-investment grade
(fair value)4212210
Total$21$695$1,573$213
Interests purchased in the secondary market (fair value)
Investment grade $7$91$102$
Non-investment grade 2871
Total$35$162$102$
Derivative assets (fair value) $$$$216
Derivative liabilities (fair value) 178

At December 31, 2017
RMLCMLU.S. Agency CMOCLN and Other1
$ in millions
SPE assets (UPB)2$15,555$62,744$11,612$17,060
Retained interests
Investment grade $$293$407$4
Non-investment grade
(fair value)198478
Total$1$391$407$482
Interests purchased in the secondary market (fair value)
Investment grade $$94$439$
Non-investment grade 16664
Total$16$160$439$4
Derivative assets (fair value) $1$$$226
Derivative liabilities (fair value) 85

RML—Residential mortgage loans

CML—Commercial mortgage loans

1. Amounts include CLO transactions managed by unrelated third parties.

2. Amounts include assets transferred by unrelated transferors.  

Fair Value at December 31, 2018
$ in millionsLevel 2Level 3Total
Retained interests
Investment grade $1,580$13$1,593
Non-investment grade 174252426
Total$1,754$265$2,019
Interests purchased in the secondary market
Investment grade $193$7$200
Non-investment grade 831699
Total$276$23$299
Derivative assets$121$95$216
Derivative liabilities1753178

Fair Value at December 31, 2017
$ in millionsLevel 2Level 3Total
Retained interests
Investment grade $407$4$411
Non-investment grade 22555577
Total$429$559$988
Interests purchased in the secondary market
Investment grade $531$2$533
Non-investment grade 572986
Total$588$31$619
Derivative assets$78$149$227
Derivative liabilities81485

The previous tables include transactions with SPEs in which the Firm, acting as principal, transferred financial assets with continuing involvement and received sales treatment.

Transferred assets are carried at fair value prior to securitization, and any changes in fair value are recognized in the income statements. The Firm may act as underwriter of the beneficial interests issued by these securitization vehicles, for which Investment banking revenues are recognized. The Firm may retain interests in the securitized financial assets as one or more tranches of the securitization. These retained interests are generally carried at fair value in the balance sheets with changes in fair value recognized in the income statements.

Proceeds from New Securitization Transactions and Sales of Loans
$ in millions201820172016
New transactions1$23,821$23,939$18,975
Retained interests2,9042,3372,701
Sales of corporate loans to
CLO SPEs1, 2317191475

1. Net gains on new transactions and sales of corporate loans to CLO entities at the time of the sale were not material for all periods presented.

2. Sponsored by non-affiliates.

The Firm has provided, or otherwise agreed to be responsible for, representations and warranties regarding certain assets transferred in securitization transactions sponsored by the Firm (see Note 12).

Assets Sold with Retained Exposure
AtAt
December 31,December 31,
$ in millions20182017
Gross cash proceeds from sale of assets1$27,121$19,115
Fair value
Assets sold$26,524$19,138
Derivative assets recognized
in the balance sheets164176
Derivative liabilities recognized
in the balance sheets763153

1. The carrying value of assets derecognized at the time of sale approximates gross cash proceeds.

The Firm enters into transactions in which it sells securities, primarily equities and contemporaneously enters into bilateral OTC derivatives with the purchasers of the securities, through which it retains exposure to the sold securities.


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/26/194,  424B2,  FWP
For Period end:12/31/1811-K,  13F-HR,  FWP,  SC 13G
12/31/1710-K,  11-K,  13F-HR,  13F-HR/A
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/24  Morgan Stanley                    10-K       12/31/23  224:45M
 2/24/23  Morgan Stanley                    10-K       12/31/22  227:50M
 2/24/22  Morgan Stanley                    10-K       12/31/21  225:51M
 2/26/21  Morgan Stanley                    10-K       12/31/20  225:50M
Top
Filing Submission 0001193125-19-051943   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 12:33:00.1pm ET